Overview
Tohru Hirato practices in Kobe, Japan. Hirato is rated as an Advanced expert by MediFind in the treatment of Multiple Sulfatase Deficiency. Their top areas of expertise are Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome), and Multiple Sulfatase Deficiency.
Their clinical research consists of co-authoring 16 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Multiple Sulfatase Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
- Advanced
- Mucopolysaccharidoses (MPS)
- Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)
- Multiple Sulfatase Deficiency
- Experienced
- Fabry DiseaseHirato isExperienced. Learn about Fabry Disease.
- Growth Hormone Deficiency (GHD)Hirato isExperienced. Learn about Growth Hormone Deficiency (GHD).
- HypopituitarismHirato isExperienced. Learn about Hypopituitarism.